These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15208819)

  • 21. Neuropathies associated with oxaliplatin therapy.
    Han C; McKeage M
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):107-10. PubMed ID: 22524568
    [No Abstract]   [Full Text] [Related]  

  • 22. Estimation of the glomerular filtration rate in cancer patients: a new formula for new drugs.
    Murray PT; Ratain MJ
    J Clin Oncol; 2003 Jul; 21(14):2633-5. PubMed ID: 12860937
    [No Abstract]   [Full Text] [Related]  

  • 23. Interindividual differences in oxaliplatin pharmacokinetics.
    Junker AM; Pieck AC; Wehmeier A; Jaehde U
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):569-70. PubMed ID: 12503817
    [No Abstract]   [Full Text] [Related]  

  • 24. Nursing Care of Patients Undergoing Chemotherapy Desensitization: Part II.
    Jakel P; Carsten C; Carino A; Braskett M
    Clin J Oncol Nurs; 2016 Apr; 20(2):137-9. PubMed ID: 26991706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of monoclonal antibodies in oncology.
    Marrs J
    Clin J Oncol Nurs; 2004 Jun; 8(3):311-3, 315. PubMed ID: 15208827
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemoradiation an effective but toxic therapy for colorectal cancer.
    Oncology (Williston Park); 1999 Sep; 13(9):1220. PubMed ID: 10509319
    [No Abstract]   [Full Text] [Related]  

  • 27. Dermatologic assessment from a distance: the use of teledermatology in an outpatient chemotherapy infusion center.
    Gordon J
    Clin J Oncol Nurs; 2012 Aug; 16(4):418-20. PubMed ID: 22842694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moving ahead: challenges with combination therapies for colorectal cancer.
    ONS News; 2004; 19(9 Suppl):13-4. PubMed ID: 15478568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Investigating the incidence of injection-site reactions associated with administration of oxaliplatin into a peripheral vein and management local adverse reactions].
    Hibi S; Tatematsu M; Nishio S; Miyatani M; Tosaki K; Ohara M; Maeda T; Tomita N; Kawai M; Ina K; Oishi K; Muro K
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1447-52. PubMed ID: 21918339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do we make progress in elderly patients with metastatic colorectal cancer?
    Glimelius B; Pfeiffer P
    Acta Oncol; 2018 Nov; 57(11):1422-1426. PubMed ID: 30384805
    [No Abstract]   [Full Text] [Related]  

  • 31. Where Do We Stand With Aspirin for the Prevention of Colorectal Cancer? The USPSTF Recommendations.
    Chan AT; Ladabaum U
    Gastroenterology; 2016 Jan; 150(1):14-8. PubMed ID: 26602220
    [No Abstract]   [Full Text] [Related]  

  • 32. Recurrent episodes of involuntary masticatory spasms induced by continuous infusion of oxaliplatin.
    Santini D; Vincenzi B; La Cesa A; Casale M; Salvinelli F; Tonini G
    J Natl Cancer Inst; 2003 Oct; 95(20):1555-6. PubMed ID: 14559882
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosis and management of colorectal cancer.
    Perston Y
    Nurs Times; 2011 Nov 15-21; 107(45):16. PubMed ID: 22167969
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapy and biotherapeutic agents for autoimmune diseases.
    Zack E
    Clin J Oncol Nurs; 2012 Aug; 16(4):E125-32. PubMed ID: 22842697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New recommendations in oncocardiology].
    Nagy CA; Lódi M; Balogh I; Czuriga D; Kocsis J
    Magy Onkol; 2017 Sep; 61(3):219-227. PubMed ID: 28931095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxaliplatin: bimonthly, biweekly, or semimonthly? No, fortnightly!
    Seymour MT
    J Clin Oncol; 2002 Sep; 20(17):3753. PubMed ID: 12202683
    [No Abstract]   [Full Text] [Related]  

  • 37. Cervical dissecting extravasation of oxaliplatin: A case report.
    Hernando J; Riera-Arnau J; Roca M; Garcia A; Capdevila J
    Mol Clin Oncol; 2022 Mar; 16(3):60. PubMed ID: 35127085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Exercise Rehabilitation Program in Relieving Oxaliplatin Induced Peripheral Neurotoxicity.
    Gui Q; Li D; Zhuge Y; Xu C
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):705-709. PubMed ID: 33773532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver.
    Said R; Kurzrock R; Naing A; Hong DS; Fu S; Piha-Paul SA; Wheler JJ; Janku F; Kee BK; Bidyasar S; Lim J; Wallace M; Tsimberidou AM
    Invest New Drugs; 2015 Aug; 33(4):911-20. PubMed ID: 25990659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxaliplatin-Induced Peripheral Neuropathy via TRPA1 Stimulation in Mice Dorsal Root Ganglion Is Correlated with Aluminum Accumulation.
    Park JH; Chae J; Roh K; Kil EJ; Lee M; Auh CK; Lee MA; Yeom CH; Lee S
    PLoS One; 2015; 10(4):e0124875. PubMed ID: 25928068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.